FOLLICULAR LYMPHOMA (FL)
Clinical trials for FOLLICULAR LYMPHOMA (FL) explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA (FL) trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA (FL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to outperform standard care in lymphoma
Disease control OngoingThis study tests a new drug, odronextamab, combined with chemotherapy against the usual treatment (rituximab plus chemo) for people with untreated follicular lymphoma, a slow-growing blood cancer. About 733 participants will be enrolled to see if the new combination works better …
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 09:19 UTC
-
New CAR-T therapy shows promise in Late-Stage lymphoma trial
Disease control OngoingThis phase 3 study tests whether a one-time infusion of tisagenlecleucel (a CAR-T cell therapy) works better than standard treatments for adults with follicular lymphoma that has returned or stopped responding after at least two prior therapies. About 109 participants will be ran…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 09:19 UTC